DMAE for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

DMAE for Health & Longevity

Created on 09/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

DMAE, an inexpensive relative of the nutrient choline, is an oral dietary supplement sold for focus and mood and a cream ingredient for skin firmness. Human evidence is thin and mostly decades old, giving little support for it as a longevity tool: effects are modest and uncertain, and lifespan findings come only from animals. Drowsiness, confusion, headache and poor sleep are the most consistent side effects. (Full Review)

Protocol

Standard oral protocol
150 mg DMAE bitartrate daily
About 55 mg DMAE base; trials used 500–1,800 mg deanol daily
Time of day
Morning, with or after breakfast
Second dose no later than early afternoon
Topical protocol
3% DMAE gel or cream
Applied once daily to the face for 16 weeks
Time to effect
Child attention
3 months
Point at which attention was assessed
Oral mood effects
3–4 weeks
Seen in older adults with dementia
Topical firming
Within hours
Wrinkle changes took 16 weeks

Benefits

Contraindications
  • Pregnant or breastfeeding women and women trying to conceive
  • Epilepsy (particularly grand mal seizures)
  • Bipolar disorder or a history of hypomania
  • Schizophrenia or other psychotic disorders
  • Uncontrolled hypertension (above 160/100 mm Hg)
  • Moderate-to-severe dementia
  • Children, outside medical supervision
  • Athletes subject to anti-doping rules using centrophenoxine
  • Antipsychotics in schizophrenia (haloperidol, risperidone, olanzapine)
  • Anticonvulsants in epilepsy (valproate, levetiracetam, lamotrigine)
    •
Key Interactions
  • Anticholinergic drugs (oxybutynin, benztropine, amitriptyline, scopolamine)
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)
  • Antidepressants and mood stabilizers (sertraline, bupropion, lithium)
  • Antihypertensives (lisinopril, amlodipine, losartan)
  • Over-the-counter sedating antihistamines (diphenhydramine, doxylamine, meclizine)
  • Over-the-counter decongestants (pseudoephedrine, phenylephrine)
  • Cholinergic supplements (citicoline, alpha-GPC, huperzine A, centrophenoxine)
  • Stimulants (caffeine, other cognition-enhancing stimulants)
  • Other interventions (topical retinoids, alpha-hydroxy acids)
    •

Risk & Side Effects

  • High: Drowsiness, confusion, insomnia and headache
    •
  • Medium: Blood pressure elevation; seizures and serious cardiac events
    •
  • Low: Mood destabilization and worsening psychosis; eye irritation and vision disturbance from vapor or liquid
    •
  • Speculative: Neural tube defects in pregnancy; skin cell swelling and damage to collagen-making cells; reduced brain choline supply
    •

Monitoring

Marker Target Why
Blood pressure Below 120/80 mm Hg Detect DMAE-related rises
Resting heart rate 50–70 beats per minute Detect cholinergic slowing or stimulation
PHQ-9 depression score 0–4 Detect mood destabilization
Cognitive score (MoCA or computerized test) MoCA 26–30; track change from own baseline Define cognitive success
ALT (liver enzyme) Below 25 U/L General liver safety
Pregnancy test (hCG) Negative Exclude pregnancy

Cadence: Baseline before starting; home blood pressure weekly for 4 weeks, then monthly; PHQ-9 and sleep review at 2 and 4 weeks; cognitive retesting at 8–12 weeks, then every 6 months while continuing

Qualitative Assessment

  • Mental energy and alertness through the afternoon
  • Sleep onset time and dream intensity
  • Mood stability, irritability and motivation
  • Word-finding and short-term memory in daily tasks
  • Skin firmness and fine-line appearance in standardized photos (topical use)
  • Headache, jaw or neck muscle tension
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.